First introduced by PROTACs (proteolysis targeting chimeras), TPDs are highly specific molecules that degrade undesirable or harmful proteins by harnessing the cell’s native degradation machinery to selectively remove these disease-causing or otherwise adverse proteins. They contain three main components: a protein of interest binding moiety, a linker and the E3 ligase binding moiety. PROTACs form a ternary complex by binding with the E3 ligase and target protein. Ubiquitination is what subsequently causes the degradation of the protein.

















